Abstract
Abstract
Background
Although the Life-Sustaining Treatment (LST) Decision Act was enforced in 2018 in Korea, data on whether it is well established in actual clinical settings are limited. Hospital-acquired pneumonia (HAP) is a common nosocomial infection with high mortality. However, there are limited data on the end-of-life (EOL) decision of patients with HAP. Therefore, we aimed to examine clinical characteristics and outcomes according to the EOL decision for patients with HAP.
Methods
This multicenter study enrolled patients with HAP at 16 referral hospitals retrospectively from January to December 2019. EOL decisions included do-not-resuscitate (DNR), withholding of LST, and withdrawal of LST. Descriptive and Kaplan–Meier curve analyses for survival were performed.
Results
Of 1,131 patients with HAP, 283 deceased patients with EOL decisions (105 cases of DNR, 108 cases of withholding of LST, and 70 cases of withdrawal of LST) were analyzed. The median age was 74 (IQR 63–81) years. The prevalence of solid malignant tumors was high (32.4% vs. 46.3% vs. 54.3%, P = 0.011), and the ICU admission rate was lower (42.9% vs. 35.2% vs. 24.3%, P = 0.042) in the withdrawal group. The prevalence of multidrug-resistant pathogens, impaired consciousness, and cough was significantly lower in the withdrawal group. Kaplan–Meier curve analysis revealed that 30-day and 60-day survival rates were higher in the withdrawal group than in the DNR and withholding groups (log-rank P = 0.021 and 0.018). The survival of the withdrawal group was markedly decreased after 40 days; thus, the withdrawal decision was made around this time. Among patients aged below 80 years, the rates of EOL decisions were not different (P = 0.430); however, mong patients aged over 80 years, the rate of withdrawal was significantly lower than that of DNR and withholding (P = 0.001).
Conclusions
After the LST Decision Act was enforced in Korea, a DNR order was still common in EOL decisions. Baseline characteristics and outcomes were similar between the DNR and withholding groups; however, differences were observed in the withdrawal group. Withdrawal decisions seemed to be made at the late stage of dying. Therefore, advance care planning for patients with HAP is needed.
Funder
Korea Centers for Disease Control and Prevention
Chung-Ang University
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Health (social science),Issues, ethics and legal aspects
Reference29 articles.
1. Proulx K, Jacelon C. Dying with dignity: the good patient versus the good death. Am J Hosp Palliat Care. 2004. https://doi.org/10.1177/104990910402100209.
2. Medicine TTFoKSoCC. Korean Professional Consensus for Comfort Care and Withdrawing/Withholding in the Intensive Care Unit. 2018. https://www.ksccm.org/modules/setting/subPageManager/user/core/view/67/stopprolongation/inc/data/ethics_Stop_prolongation.pdf. Accessed 2 Nov 2022.
3. Angus DC, Barnato AE, Linde-Zwirble WT, Weissfeld LA, Watson RS, Rickert T, et al. Use of intensive care at the end of life in the United States: an epidemiologic study. Crit Care Med. 2004. https://doi.org/10.1097/01.ccm.0000114816.62331.08.
4. Carter HE, Winch S, Barnett AG, Parker M, Gallois C, Willmott L, et al. Incidence, duration and cost of futile treatment in end-of-life hospital admissions to three Australian public-sector tertiary hospitals: a retrospective multicentre cohort study. BMJ Open. 2017. https://doi.org/10.1136/bmjopen-2017-017661.
5. center Kli. Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life. 2018. https://www.law.go.kr/LSW/eng/engLsSc.do?y=0&x=0&menuId=2&query=life-sustaining+treatment+§ion=lawNm#liBgcolor0. Accessed 28 Oct 2022.